Read interviews, first-person essays, profiles, and other features about
people in a wide variety of fields, along with information on journals
& institutions in the topic of Diabetes. All of the author comments
below are also listed in the site-wide
Author Commentaries listings
(available by month/year or alphabetically).
September
2009
Philip Raskin; According to the Special Topics
Research Front Map on Insulin Treatment of Type 2 Diabetes, the
paper "Initiating insulin therapy in type 2 diabetes—a
comparison of biphasic and basal insulin analogs" (Raskin P,
et al., Diabetes Care 28[2]: 260-5, February 2005) is
a key paper, with 178 cites to its credit. In this interview,
ScienceWatch.com's Jennifer Minnick talks with lead
author Dr. Philip Raskin about this paper and its impact on the
field. View
Article
August
2009
Mark Cooper; In our Special Topics analysis of
diabetes research over the past decade, the work of Dr. Mark
Cooper ranks at #6 by total cites, based on 130 papers cited a
total of 6,085 times. According to Essential Science
IndicatorsSM from Clarivate, Dr. Cooper's
record includes 246 papers, the majority of which are
classified under Clinical Medicine, cited a total of 7,787
times. ScienceWatch.com correspondent Gary Taubes
talks with Dr. Cooper about his highly cited work in this
field. View
Article
July
2009
David Nathan; In our Special Topics analysis on
diabetes research over the past decade, the work of Dr. David
Nathan ranks at #7 by total cites, and #1 by cites/paper, based
on 72 papers cited a total of 6,040 times. According to
Essential Science IndicatorsSM from Thomson
Reuters, his record includes 102 papers, cited a total of 8,333
times. In this interview, Dr. Nathan, talks with
ScienceWatch.com correspondent Gary Taubes about his
highly cited work. View
Article
June
2009
JoAnn Manson; According to our 2009 Special Topics
analysis of diabetes research, the work of Dr. JoAnn E. Manson
ranks at #8 by total cites, based on 102 papers cited a total
of 6,033 times. In Essential Science
IndicatorsSM from Clarivate, Dr. Manson
is in the top 1% of authors in the field of Clinical Medicine.
In this interview, she talks with ScienceWatch.com
about her highly cited work in diabetes. View
Article
June
2009
Bo Ahrén; In our Special Topics analysis of
diabetes research over the past decade, the paper "Inhibition
of dipeptidyl peptidase IV improves metabolic control over a 4
week study period in type 2 diabetes," (Ahrén B, et
al., Diabetes Care 25:869-875 [2002]) is the #1 paper in
the Research
Front Map Dipeptidyl Peptidase-4 Inhibition Treatment of
Type 2 Diabetes. Lead author Dr. Bo Ahrén is the Dean of
the Faculty of Medicine at Lund University in Sweden, and in
this interview, he talks with ScienceWatch.com about
this paper and its impact on the research community. View
Article